Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04943_nanopub.RAbye4lLSxJAeT8RaDMEdXZIriARNDt6zE_2PbIB-o5VA#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04943 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04943 label "LX201 [drugbank:DB04943]" assertion.
- drugbank:DB04943 seeAlso DB04943 assertion.
- drugbank:DB04943 description "LX201 is a silicone matrix ocular implant that provides sustained release of cyclosporine A (CsA) locally to the eye over the course of one year. LX201 is implanted subconjunctivally (beneath the transparent membrane covering the white of the eye) in a minimally invasive procedure. The implant is being developed clinically for the prevention of rejection in corneal transplantation. It is being developed by Lux Biosciences, Inc." assertion.
- drugbank:DB04943 identifier "drugbank:DB04943" assertion.
- drugbank:DB04943 title "LX201" assertion.
- drugbank:DB04943 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04943 drugbank_vocabulary:drugbank-id "DB04943" assertion.
- drugbank:DB04943 bio2rdf_vocabulary:x-identifiers.org DB04943 assertion.
- drugbank:DB04943 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04943" assertion.
- drugbank:DB04943 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04943 bio2rdf_vocabulary:identifier "DB04943" assertion.